Gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: A comprehensive review.
Gaspar Del Rio-PertuzNandini NairPublished in: Artificial organs (2022)
CF-LVAD-supported patients have a significant risk of GI bleeding that is mainly caused by arteriovenous malformations located in the upper GI tract. The increased prevalence of GI bleeding in CF-LVAD patients is attributed to several etiologies that include factors attributed to the device itself and extrinsic factors such as the use of anticoagulation.
Keyphrases
- end stage renal disease
- newly diagnosed
- left ventricular
- ejection fraction
- chronic kidney disease
- cystic fibrosis
- atrial fibrillation
- prognostic factors
- peritoneal dialysis
- acute myocardial infarction
- patient reported outcomes
- mitral valve
- aortic stenosis
- hypertrophic cardiomyopathy
- transcatheter aortic valve replacement
- left atrial
- aortic valve